Navigation Links
PARI Respiratory Launches PEP S
Date:10/1/2009

MIDLOTHIAN, Va., Oct. 1 /PRNewswire/ -- Today, PARI Respiratory Equipment introduced the PEP S, a device that provides positive expiratory pressure that can be used with all PARI LC reusable nebulizers. PARI's PEP S can be used alone or in combination with nebulizer therapies for airway clearance and lung strengthening exercises by cystic fibrosis patients.

"I believe the new PARI PEP S is an incredible new device that improves patient care in two very important areas. It reduces treatment time by combining the PEP procedure with needed nebulized treatments. It may also enhance medication deposition with effective airway clearance during the nebulized treatment, especially in patients that find other modes of airway clearance cumbersome," said Dr. Sterling Simpson, pediatric pulmonologist, East Tennessee Children's Hospital.

"PARI is continually striving to improve respiratory therapies, and the PEP S is a time saver for cystic fibrosis patients. The PEP S allows for combination therapy with all of our LC reusable nebulizers, including the LC Sprint," said Geoff A. Hunziker, president of PARI Respiratory Equipment.

PARI's PEP S has eight adjustable resistance settings, covering a large expiratory flow range while achieving optimal resistance rates. Patients suffering from cystic fibrosis, lung diseases with secretory problems, and atelectasis (collapse of part or all of a lung) use PEP therapy to improve lung function by loosening thick, sticky mucus. PEP therapy has been shown to increase response to inhaled bronchodilators and is recommended by both the Cystic Fibrosis Foundation and the American Association for Respiratory Care.

About Cystic Fibrosis (CF)

Today, more than 30,000 people in the United States have CF. CF is a chronic, debilitating genetic disease. A major characteristic of CF is production of abnormally thick, sticky mucus in the lungs, trapping bacteria and predisposing patients to lung infections, which continually damage their lungs.

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Maker of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. Its Vortex Holding Chamber's anti-static, valved holding chamber improves the aerosol deposition of metered dose inhalers (MDIs). PARI's North American headquarters is in Midlothian, VA with worldwide headquarters in Starnberg, Germany. Online at www.Pari.com

SOURCE PARI Respiratory Equipment, Inc.


'/>"/>
SOURCE PARI Respiratory Equipment, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting
2. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
3. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
4. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
5. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
6. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
9. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
10. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
11. Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):